CD56bright human NK cells differentiate into CD56dim cells: Role of contact with peripheral fibroblasts

Journal of Immunology

Volumn 179, Issue 1, 2007, Pages 89-94

  Chan, Antoni ^a   Hong, Deng Li ^a   Atzberger, Ann ^a   Kollnberger, Simon ^a   Filer, Andrew D ^b   Buckley, Christopher D ^b   McMichael, Andrew ^a   Enver, Tariq ^a   Bowness, Paul ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD16 ANTIGEN; CD56 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GAMMA INTERFERON; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH INHIBITOR; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CELL CONTACT; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN K 562; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; FIBROBLAST; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; ADULT; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL COMMUNICATION; CELL CULTURE; CELL PROLIFERATION; COCULTURE; COMPARATIVE STUDY; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; METABOLISM; PHYSIOLOGY; PROSPECTIVE STUDY; SYNOVIUM;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD56; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; FIBROBLASTS; GROWTH INHIBITORS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MODELS, IMMUNOLOGICAL; PROSPECTIVE STUDIES; RECEPTORS, FIBROBLAST GROWTH FACTOR; SYNOVIAL MEMBRANE;

EID: 34250802584     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.179.1.89     Document Type: Article

References (28)

1. Farag, S. S., and M. A. Caligiuri. 2006. Human natural killer cell development and biology. Blood Rev. 20: 123-137.
2. Cooper, M. A., T. A. Fehniger, and M. A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22: 633-640.
3. bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Eur. J. Immunol. 27: 354-360.
4. bright subset. Blood 97: 3146-3151.
5. Farag, S. S., J. B. Van Deusen, T. A. Fehniger, and M. A. Caligiuri. 2003. Biology and clinical impact of human natural killer cells. Int. J. Hematol. 78: 7-17.
6. Colucci, F., M. A. Caligiuri, and J. P. Di Santo. 2003. What does it take to make a natural killer? Nat. Rev. Immunol. 3: 413-425.
7. Farag, S. S., and M. A. Caligiuri. 2006. Human natural killer cell development and biology. Blood Rev. 20: 123-137.
8. Nagler, A., L. L. Lanier, S. Cwirla, and J. H. Phillips. 1989. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 143: 3183-3191.
9. Root, L. L., and G. D. Shipley. 2000. Normal human fibroblasts produce membrane-bound and soluble isoforms of FGFR-1. Mol. Cell Biol. Res. Commun. 3: 87-97.
10. + T cell migration within synovial tissue. Arthritis Rheum. 48: 2472-2482.
11. Whiteside, T. L., J. Bryant, R. Day, and R. B. Herberman. 1990. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J. Clin. Lab. Anal. 4: 102-114.
12. Warren, H. S. 1999. Using carboxyfluorescein diacetate succinimidyl ester to monitor human NK cell division: analysis of the effect of activating and inhibitory class I MHC receptors. Immunol. Cell Biol. 77: 544-551.
13. Loza, M. J., and B. Perussia. 2001. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat. Immunol. 2: 917-924.
14. Rufer, N., W. Dragowska, G. Thornbury, E. Roosnek, and P. M. Lansdorp. 1998. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat. Biotechnol. 16: 743-747.
15. Shultz, L. D., P. A. Schweitzer, S. W. Christianson, B. Gott, I. B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T. V. Rajan, D. L. Greiner, et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154: 180-191.
16. Lanier, L. L., R. Testi, J. Bindl, and J. H. Phillips. 1989. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J. Exp. Med. 169: 2233-2238.
17. Williams, E. J., J. Fumess, F. S. Walsh, and P. Doherty. 1994. Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron 13: 583-594.
18. Anderson, A. A., C. E. Kendal, M. Garcia-Maya, A. V. Kenny, S. A. Morris-Triggs, T. Wu, R. Reynolds, E. Hohenester, and J. L. Saffell. 2005. A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survival. J. Neurochem. 95: 570-583.
19. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 173: 6418-6426.
20. Parsonage, G., A. D. Filer, O. Haworth, G. B. Nash, G. E. Rainger, M. Salmon, and C. D. Buckley. 2005. A stromal address code defined by fibroblasts. Trends Immunol. 26: 150-156.
21. + progenitors via cell surface IL-15. J. Immunol. 168: 4326-4332.
22. +hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol. Dis. 27: 731-743.
23. dim natural killer cell subsets. J. Immunol. 161: 400-408.
24. Young, N. T., and M. Uhrberg. 2002. KIR expression shapes cytotoxic repertoires: a developmental program of survival. Trends Immunol. 23: 71-75.
25. Farag, S. S., T. A. Fehniger, L. Ruggeri, A. Velardi, and M. A. Caligiuri. 2002. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 100: 1935-1947.
26. Hanna, J., P. Bechtel, Y. Zhai, F. Youssef, K. McLachlan, and O. Mandelboim. 2004. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J. Immunol. 173: 6547-6563.
27. Ferlazzo, G., D. Thomas, S. L. Lin, K. Goodman, B. Morandi, W. A. Muller, A. Moretta, and C. Munz. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172: 1455-1462.
28. Freud, A. G., A. Yokohama, B. Becknell, M. T. Lee, H. C. Mao, A. K. Ferketich, and M. A. Caligiuri. 2006. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 203: 1033-1043.